AMAT
59
4
EXPE
81
-2
ZBH
80
14
BF.B
31
3
DHR
46
-4
MMM
54
2
QRVO
51
15
AN
65
2
AZO
50
5
PYPL
62
6
VIX
38
-6
ORLY
45
2
AON
47
-2
CAH
54
-2
D
55
2
PEG
65
-2
MUR
30
-4
HES
68
2
EQR
39
-3
NRG
45
-5
AMAT
59
4
EXPE
81
-2
ZBH
80
14
BF.B
31
3
DHR
46
-4
MMM
54
2
QRVO
51
15
AN
65
2
AZO
50
5
PYPL
62
6
VIX
38
-6
ORLY
45
2
AON
47
-2
CAH
54
-2
D
55
2
PEG
65
-2
MUR
30
-4
HES
68
2
EQR
39
-3
NRG
45
-5
Financhill
Back

NovoCure Stock Predictions

Access "King of the Quants" Stock Rating System FREE!

[Claim Your 3 Free Grades Now]
Sell
32

NVCR
NovoCure

Last Price:
$26.16
Seasonality Move:
1.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Access to "King of the Quants" Stock Rating System

[Claim Your 3 Free Grades Now]

NovoCure Stock Forecast

  • Over the next 52 weeks, NovoCure has on average historically risen by 47.5% based on the past 9 years of stock performance.
  • NovoCure has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is NovoCure Stock Undervalued?
    The current NovoCure [NVCR] share price is $26.17. The Score for NVCR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will NovoCure Stock Go Up Next Year?

  • Over the next 52 weeks, NovoCure has on average historically risen by 47.5% based on the past 9 years of stock performance.

NovoCure Stock Rating

Sell
32
NovoCure (NVCR) is a Sell

Is NovoCure overpriced?

  • NovoCure has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

NovoCure Stock Price History

Is NVCR stock going to rise?

  • The current trend is moderately bearish and NVCR is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Jersey
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
novocure.com

52-Week Data

52-Week High:
34.13
52-Week Low:
11.70

Prediction Charts

Market Cap:
2.8B
Price in USD:
26.17
Volume:
1.2M
Beta:
1.04

Technical Analysis

SMA50:
25.23
SMA100:
20.98
SMA200:
19.49
52-Wk Change:
110.71%

Stock Predictions

  • Is NovoCure stock public?
    Yes, NovoCure is a publicly traded company.
  • What is the NovoCure stock quote today?
    The NovoCure stock price is 26.17 USD today.
  • How to buy NovoCure stock online?
    You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-27 31.74 30.70 32.06 30.38
Dec-30 30.28 30.08 30.81 29.78
Dec-31 30.30 29.80 30.87 29.62
Jan-2 30.54 29.99 31.17 29.85
Jan-3 30.33 30.19 30.63 29.80
Jan-6 30.35 29.66 30.78 29.49
Jan-7 29.50 29.01 29.80 28.71
Jan-8 28.65 28.91 29.29 28.19
Jan-10 28.04 27.45 28.56 27.16
Jan-13 27.45 27.38 28.13 26.43
Jan-14 27.22 26.23 27.60 26.15
Jan-15 27.05 26.35 27.70 26.32
Jan-16 26.30 26.02 26.63 25.46
Jan-17 25.66 26.17 27.11 25.66

NovoCure Earnings

NovoCure Earnings Report: Per Share NovoCure Earnings Q1 Q2 Q3 and Q4 last year and next year.

NovoCure Forecast Revenue Growth

NovoCure Stock Analysis: Historical quarterly revenues per share for NovoCure and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.03 per share.

* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.